Location out of bounds


Resources for journalists

All Publications
Hervé Falet, PhD working with an assistant in his lab

Filling in the gaps to better understand platelet production

Milwaukee – April 8, 2019

Understanding platelets on a cellular level

Versiti Blood Research Institute Investigator Hervé Falet, PhD, is using his expertise in hematology and cell biology to identify gaps in knowledge of the platelet production process.

Platelets are only one component of blood, in addition to red cells, white cells and plasma. Platelets help the blood to clot, and an overabundance or lack of them can be detrimental to an individual’s health. In normal, healthy individuals, platelet counts are somewhere between 150,000-450,000, and gene mutations can cause a platelet count to change within that range. However, platelet counts above or below those two end points can cause serious health issues. Patients with a platelet count below 150,000 experience thrombocytopenia, or a lack of platelets that causes the blood to have difficulty clotting, increasing the risk of bleeding. Patients with a platelet count greater than 450,000 experience thrombocytosis, or an excessive number of platelets, which increases the risk of blood clots, stroke and heart attack, the leading cause of death in the United States.

A key aspect to understanding platelet production and function is studying megakaryocytes. Megakaryocytes are the cells in the body’s bone marrow that produce platelets. These cells form from hematopoietic stem cells, multiply their DNA content through endomitosis, or the replication of chromosomes in the absence of cell division, and expand to form an intracellular maze of membranes, called the demarcation membrane system, from which platelet territories are formed.

Dr. Falet and his peers already know that megakaryocytes can migrate closer to blood vessels, where they release platelets, but no one knows quite how the platelet territories are formed within the cell membranes. Dr. Falet is interested in learning more about the different genes and proteins that play a role in intracellular membrane formation and organization, and platelet production.

Researchers have already identified certain proteins in the body that can affect an individual’s platelets, such as dynamin 2 (DNM2), mutations of which cause neuromuscular diseases associated with low platelet counts and acute lymphoblastic leukemia, and PACSIN2, which affects platelet count and size. By better understanding how these genes affect platelet production, investigators like Dr. Falet can work toward improving platelet counts and developing new treatment methods for patients.

About the expert: Hervé Falet, PhD, is an investigator at the Versiti Blood Research Institute and assistant professor in the Department of Cell Biology, Neurobiology and Anatomy at the Medical College of Wisconsin.


Hervé Falet, PhD

View Bio > Call: Fax: Email: HFalet@Versiti.org
Herve Falet, PhD

Other Publications

Blood samples in tubes.

How Versiti researchers are helping patients with atherosclerosis

November 7, 2019

Postdoctoral fellow Bandana Singh, PhD, believes Versiti Blood Research Institute is poised to make a big impact in the field of vascular biology.

Read More
Weiguo Cui, MD, PhD performing laboratory research

Versiti leads the way in novel, cellular-based immunotherapies

October 23, 2019

Investigator Weiguo Cui, MD, PhD, believes T cells are the key to fighting solid tumors in cancer patients.

Read More
Laboratory tests with blood samples.

Understanding the immune system's ability to eliminate cancer cells

October 22, 2019

Associate Investigator Matthew Riese, MD, PhD, hopes to use a patient’s own immune system to fight cancer.

Read More

This website uses cookies to ensure you get the best experience on our website. Learn more